Which bladder control supplements are best? Involuntary urination is a scary condition for most people, and specific medical issues, stress or aging can lead to incontinence. But there are steps you ...

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) ...

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

FREMONT, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, announced that it has introduced Power Control software for IQ9™ and IQ8™ ...

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA)ImmunityBio established a wholly owned subsidiary in the Kingdom of Saudi ...

If you're losing sleep because you have to pee in the middle of the night, there are five habits you might want to try. Aly Lopez Former Writer I Aly Lopez was a writer on the sleep and wellness team ...

FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal clinical study was selected for presentation on the ...

Whether you are struggling with a severe stomach ache or you are celebrating a new pregnancy, a doctor's firstcall is often an ultrasound. We have all been there - sitting in a waiting room holding ...

Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...

The announcement comes days after local peer Lupin decided to settle its dispute with Astellas over the same drug for $90 million. Reuters Zydus Lifesciences and its US unit will pay $120 million to ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Anna Wenner A former pick, the Beyond XP5000 Plastic-Backed Adult Brief, has ...

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...